Switch theme
Sign up to access all valuation multiples
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company’s lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.
2011
87
Last FY Revenue n/a
LTM EBITDA -$128M
$296M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Celcuity has a last 12-month revenue (LTM) of n/a and a last 12-month EBITDA of -$128M.
In the most recent fiscal year, Celcuity achieved revenue of n/a and an EBITDA of -$101M.
Celcuity expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Celcuity valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | n/a | XXX | n/a | XXX | XXX | XXX |
| Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| Gross Margin | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA | -$128M | XXX | -$101M | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | n/a | XXX | XXX | XXX |
| EBIT | -$129M | XXX | -$113M | XXX | XXX | XXX |
| EBIT Margin | n/a | XXX | n/a | XXX | XXX | XXX |
| Net Profit | -$129M | XXX | -$112M | XXX | XXX | XXX |
| Net Margin | n/a | XXX | n/a | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $75.2M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Celcuity's stock price is $11.
Celcuity has current market cap of $403M, and EV of $296M.
See Celcuity trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $296M | $403M | XXX | XXX | XXX | XXX | $-3.05 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Celcuity has market cap of $403M and EV of $296M.
Celcuity's trades at n/a EV/Revenue multiple, and -2.9x EV/EBITDA.
Equity research analysts estimate Celcuity's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Celcuity has a P/E ratio of -3.1x.
See valuation multiples for Celcuity and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $403M | XXX | $403M | XXX | XXX | XXX |
| EV (current) | $296M | XXX | $296M | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | n/a | XXX | XXX | XXX |
| EV/EBITDA | -2.3x | XXX | -2.9x | XXX | XXX | XXX |
| EV/EBIT | -2.3x | XXX | -2.6x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | -3.1x | XXX | -3.6x | XXX | XXX | XXX |
| EV/FCF | -2.8x | XXX | -3.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialCelcuity's revenue per employee in the last FY averaged n/a, while opex per employee averaged $1.3M for the same period.
Celcuity's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Celcuity's rule of X is n/a (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Celcuity and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Growth | 28% | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $1.3M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Julphar | XXX | XXX | XXX | XXX | XXX | XXX |
| Benevolent AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Galapagos | XXX | XXX | XXX | XXX | XXX | XXX |
| Pharming | XXX | XXX | XXX | XXX | XXX | XXX |
| Vivoryon Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Celcuity acquired XXX companies to date.
Last acquisition by Celcuity was XXXXXXXX, XXXXX XXXXX XXXXXX . Celcuity acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Celcuity founded? | Celcuity was founded in 2011. |
| Where is Celcuity headquartered? | Celcuity is headquartered in United States of America. |
| How many employees does Celcuity have? | As of today, Celcuity has 87 employees. |
| Who is the CEO of Celcuity? | Celcuity's CEO is Mr. Brian F. Sullivan. |
| Is Celcuity publicy listed? | Yes, Celcuity is a public company listed on NAS. |
| What is the stock symbol of Celcuity? | Celcuity trades under CELC ticker. |
| When did Celcuity go public? | Celcuity went public in 2017. |
| Who are competitors of Celcuity? | Similar companies to Celcuity include e.g. Julphar, Benevolent AI, Galapagos, Pharming. |
| What is the current market cap of Celcuity? | Celcuity's current market cap is $403M |
| Is Celcuity profitable? | Yes, Celcuity is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Celcuity? | Celcuity's last 12 months EBITDA is -$128M. |
| What is the current EV/EBITDA multiple of Celcuity? | Current EBITDA multiple of Celcuity is -2.3x. |
| What is the current FCF of Celcuity? | Celcuity's last 12 months FCF is -$107M. |
| What is the current EV/FCF multiple of Celcuity? | Current FCF multiple of Celcuity is -2.8x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
